| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2003;42:569.)
© 2003 American Heart Association, Inc.
Scientific Contributions |
From the Division of Renal Diseases and Hypertension, Department of Medicine, The University of Texas Health Science Center, Houston, Tex.
Correspondence to Andrew M. Kahn, MD, The University of Texas Health Science Center, Houston, Medical School, 6431 Fannin St, MSB 4.148, Houston, TX 77030. E-mail Andrew.M.Kahn{at}uth.tmc.edu
| Abstract |
|---|
|
|
|---|
Key Words: muscle, smooth, vascular insulin cyclic GMP nitric oxide
| Introduction |
|---|
|
|
|---|
We have shown that insulin alone does not affect cGMP accumulation in cultured VSMCs, but when cGMP production is stimulated by a permissive amount of nitric oxide (NO), physiological concentrations of insulin increase the accumulation of cGMP.6 We found that insulin stimulates glucose uptake and aerobic glycolysis in these cells and that the resultant increase in lactate is responsible for insulins increase in NO-stimulated cGMP accumulation.6,11,12 Increased lactate in VSMCs has been reported to increase superoxide anion (O2-) production.13 O2- is well known to scavenge NO, thereby decreasing VSMC guanylate cyclase activity.14 It was unclear how to reconcile these phenomenon with our previous finding that insulin-stimulated lactate increases NO-stimulated cGMP accumulation.6,12 The present study was designed to explain these discrepant findings and determine the mechanism of insulins increase in NO-stimulated cGMP accumulation. Since reactive oxygen species have been linked to decreased phosphodiesterase activity,15,16 the first goal of these studies was to determine whether insulin increases NO-stimulated cGMP generation or inhibits its hydrolysis and/or efflux.
Omar et al13 have shown that lactate increases cGMP-mediated relaxation of endothelium-denuded vascular smooth muscle tissue from calf pulmonary artery. They demonstrated that lactates increase in NADH, caused by the action of lactate dehydrogenase, stimulates the activity of NADH oxidase that yields O2-. In other experiments with endothelium-denuded bovine pulmonary artery, they showed that hydrogen peroxide (H2O2), the product of O2- and superoxide dismutase (SOD), reacts with catalase and that the resultant intermediate form of the catalase enzyme (compound I) stimulates soluble guanylate cyclase activity.17 Others have reported that H2O2 stimulates guanylate cyclase activity in guinea pig aorta,18 rabbit urethral and cavernosal smooth muscle,19 and human platelets.20 Thus, it was possible that insulins increase in lactate in cultured VSMCs caused increased O2- and H2O2 production and the latter increased guanylate cyclase activity. The second goal of this study was to test this hypothesis.
| Methods |
|---|
|
|
|---|
Cyclic GMP Assay
Dishes of VSMCs were incubated for 30 minutes at 37°C with the desired agents in physiological salt solution (PSS) containing (in mmol/L) 136 NaCl, 4 KCl, 5 glucose, 1.8 CaCl2, 0.8 MgSO4, 10 HEPES-Tris, pH 7.4, plus 0.1% BSA. cGMP content of acetylated cell lysates was determined with a direct cGMP enzyme immunoassay kit (Assay Designs).
Superoxide Anion Assay
Dishes of VSMC were incubated for 30 minutes at 37°C with the desired agents in PSS; the cells were washed with Hanks balanced salt solution (HBSS) and released from the dishes by incubating them with collagenase (1 mg/mL), BSA (2 mg/mL), and soybean trypsin inhibitor (1 mg/mL) in HBSS at 37°C for 5 minutes. Cells were collected by centrifugation (200g for 5 minutes at 4°C), and the cell pellet was resuspended in HBSS; 20 µL of 2.5 mmol/L dark-adapted lucigenin in HBSS was added to 80 µL of cell suspension (
40 µg protein) at room temperature, and photon emission was measured every 15 seconds for 10 minutes in a luminometer (model 20/20, Turner Designs) as previously described.22 Readings stabilized by 3 minutes, and that value minus a blank value obtained in the absence of cells was recorded. O2- content of samples was obtained from a standard curve generated with the use of xanthine/xanthine oxidase, as previously described.23
Hydrogen Peroxide Assay
Dishes of cells were washed and incubated with the desired reagents in 2 mL of PSS at 37°C for 30 minutes. H2O2 content of 200 µL incubation solution was measured with the Peroxil Luminol Hydrogen Peroxide Determination Kit (World Precision Instruments). In this assay, horseradish peroxidase reacts with H2O2 to form reactive intermediates that oxidize luminol. The chemiluminescence emitted by luminol was measured in a luminometer, and H2O2 content of samples minus a blank was obtained from a standard curve with the use of authentic H2O2 in PSS.
Values for cGMP, O2-, and H2O2 varied from experiment to experiment, but the relative effects of experimental perturbations were highly reproducible among different experiments. Thus, data are expressed as a percentage of values obtained under control conditions, and the mean absolute control values are stated in the figure legends. Statistical analysis was performed on paired data by use of Student t test and ANOVA, with multiple comparisons using the Newman-Keuls test. Statistical significance was taken as a value of P<0.05.
Bovine insulin, cGMP, IBMX, BSA, diphenyliodonium (DPI), diethyldithiocarbonate (DETCA), and H2O2 were obtained from Sigma, and S-nitroso-N-acetylpenicillamine was from Alexis. Protein was measured by the method of Bradford.
| Results |
|---|
|
|
|---|
|
Effect of Insulin on O2-
Insulin increases lactate content and the lactate-to-pyruvate ratio in these cells 3-fold, as we have previously reported.12 The concomitant increase in the NADH/NAD+ ratio would be expected to increase O2- production by NADH oxidase, as has been described in other vascular smooth muscle tissue.13 As shown in Figure 2, 30-minute exposure to 1 nmol insulin increased O2- levels in these cells. DPI, an inhibitor of NADH oxidase, did not affect basal O2- but completely blocked insulin stimulation of O2- levels. DETCA, an inhibitor of SOD, increased both basal and insulin-stimulated O2- levels. These data indicate that insulin stimulates O2- production by NADH oxidase and that SOD is active in these cells.
|
O2- Metabolism and cGMP
If insulin-stimulated O2- production leads to an increase of insulin in NO-stimulated cGMP production, this effect of insulin should be blocked by DPI. As shown in Figure 3A, insulin alone had no effect on cGMP. SNAP, an NO donor, increased cGMP and insulin stimulated cGMP further, as we have previously described.6 As also shown in Figure 3A, DPI did not affect basal or SNAP-stimulated cGMP, but it blocked the further stimulation of cGMP by insulin. These data support the possibility that insulin-stimulated O2- production leads to the increase of this hormone in cGMP production. Figure 3B shows that blocking SOD with DETCA did not affect basal cGMP levels, but it partially inhibited SNAP-stimulated cGMP levels and it completely blocked the additional stimulation of cGMP by insulin. These data indicate that the metabolism of insulin-stimulated O2- by SOD to H2O2 mediates insulins increase in NO-stimulated cGMP production.
|
H2O2 and cGMP
We then tested whether insulin increases H2O2 and whether the latter stimulates guanylate cyclase activity. As shown in Figure 4A, insulin increased H2O2 levels in VSMCs. As expected, inhibiting SOD activity with DETCA decreased basal and insulin-stimulated H2O2 levels. Figure 4B shows that H2O2 alone did not affect cGMP levels in these VSMCs, but when cGMP production was stimulated by NO from iNOS, H2O2 increased cGMP levels further. Since H2O2 was present in the incubation buffer, NO was provided by iNOS instead of SNAP in this experiment because oxidizing agents retard NO release from SNAP.25 H2O2 per se did not affect iNOS activity (data not shown). These data indicate that the insulins increase in H2O2 increases NO-stimulated cGMP production.
|
| Discussion |
|---|
|
|
|---|
The mechanism of insulin-stimulated cGMP production is unknown, but we previously showed that insulin increases lactate accumulation in cultured VSMCs.12 If this effect of insulin was blocked, insulin failed to increase NO-stimulated cGMP levels. Raising lactate with specific metabolic substrates in the absence of insulin also increased NO-stimulated cGMP accumulation.12 We concluded that the insulin increase in lactate increased NO-stimulated cGMP accumulation in these cells. Increased lactate increases NADH by the lactate dehydrogenase reaction, which drives NADH oxidase toward O2- in VSMCs.13 This should scavenge NO, thereby decreasing, not increasing, guanylate cyclase activity stimulated by a finite amount of NO.
Burke et al17 showed that H2O2 reacts with catalase, which stimulates guanylate cyclase activity in VSMCs in the apparent absence of NO. This occurred immediately, and the response decayed rapidly with time. In the present study, we showed in cultured VSMCs that insulin, which increases lactate, increased O2- levels. O2- was converted to H2O2 by SOD and H2O2 increased cGMP over a 30-minute period in the permissive presence of NO. The relatively prolonged effect of H2O2 on cGMP accumulation in the present study may have been due to the presence of IBMX in the incubation buffer. When O2- production was inhibited by blocking NADH oxidase with DPI, or when H2O2 production was inhibited by blocking SOD with DETCA, insulin failed to stimulate cGMP production. Thus, the present studies confirm the findings of Burke et al and extend those findings by showing that insulin stimulates guanylate cyclase activity in cultured VSMCs by the same series of reactions.
In previous studies, we showed that insulin inhibits cultured VSMC contraction in a dose-dependent manner and that this effect is cGMP-dependent26,27; 1 nmol insulin, the concentration used in the present study, is in the physiological range in rat.28 We did not test whether maximal H2O2-stimulated cGMP production in the presence of NO was stimulated further by insulin. If it did, insulin would have increased guanylate cyclase activity by an additional mechanism.
It is unknown why cultured rat VSMCs require the permissive presence of NO for H2O2 to stimulate guanylate cyclase activity. This was also reported for rabbit urethral and cavernosal smooth muscle,19 but this was not the case for bovine vascular smooth muscle tissue17 or human platelets.20 Additional studies are necessary to answer this question.
We postulate that the increase of insulin in O2-derived H2O2 predominated over insulin increase in O2- scavenging of NO such that NO-stimulated cGMP production was overall increased by insulin. Even though the rate constant for the reaction of O2- with NO (7x109 mol/s) exceeds that for O2- with SOD (2x109 mol/s),29 under normal conditions, the relatively high abundance of SOD ensures that the latter reaction occurs preferentially.14 It is noteworthy that DETCA partially inhibited SNAP-stimulated cGMP production (Figure 3B). This may be explicable since DETCA increased basal O2- levels (Figure 2), which would be expected to increase scavenging of NO, thereby lowering overall guanylate cyclase activity in the face of inhibited H2O2 production. Gutpe et al30 found that lactate decreased NO-induced relaxation in endothelium-removed bovine pulmonary artery in the presence of DETCA, presumably because of scavenging of NO by O2-. In the present study, insulin, which increases lactate in cultured VSMCs, did not inhibit SNAP-stimulated cGMP production in the presence of DETCA (Figure 3B). The reason for this is unknown, but DETCA may not have completely blocked insulin-stimulated H2O2 production.
Perspectives
The present studies may have pathophysiological significance. Insulin-resistant states are associated with accelerated vascular disease.13 The failure of insulin to stimulate guanylate cyclase in the vascular smooth muscle of these individuals could contribute to their vascular pathology. Alternatively, it has been proposed that the hyperinsulinemia associated with those conditions can aggravate it.4,5 Although H2O2 is known to stimulate guanylate cyclase activity in several tissues, including VSM,1720 O2-, H2O2, and other oxidants are associated with accelerated vascular disease.31 In the present study, insulin increased O2- and H2O2, and the latter stimulated cGMP production. This should ameliorate vascular disease. On the basis of these studies, insulin might be expected to have beneficial or deleterious vascular effects, and it needs to be determined if the final effect of insulin on vascular pathology depends on various factors that tip the net effect of insulin one way or the other.
| Acknowledgments |
|---|
Received June 2, 2003; first decision June 9, 2003; accepted August 14, 2003.
| References |
|---|
|
|
|---|
2. Asakura Suzuki M, Nonogi H, Haze K, Sato A, Inada H, Okida Y, Yamashita K, Harano Y. Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin dependent diabetes mellitus (NIDDM). J Cardiovasc Risk. 1998; 5: 331334.[CrossRef][Medline] [Order article via Infotrieve]
3. Osani H. Kanayama H, Miyazaki Y, Fukushima A, Shinoda M, Ito T. Usefulness of enhanced insulin secretion during an oral glucose tolerance test as a predictor of restenosis after direct percutaneous transluminal coronary angioplasty during acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol. 1998; 81: 698701.[CrossRef][Medline] [Order article via Infotrieve]
4. Reaven GM, Chen YDI. Insulin resistance, its consequences, and coronary heart disease: must we choose one culprit? Circulation. 1996; 93: 17801783.
5. Sowers JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension. 1997; 29: 691699.
6. Kahn AM, Allen JC, Siedel CL, Lichtenberg DS, Zhang S. Insulin increases NO- stimulated guanylate cyclase activity in cultured VSMC while raising redox potential. Am J Physiol. 2000; 278: E627E633.
7. Sandu OA, Ito M, Begum N. Signal transduction in smooth muscle selected contribution: insulin utilizes NO/cGMP pathway to activate myosin phosphatase via Rho inhibition in vascular smooth muscle. J Appl Physiol. 2001; 91: 14751482.
8. Dubey RK, Jackson EK, Lusher TF. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell: role of cyclic-nucleotides and angiotensin1 receptor. J Clin Invest. 1995; 96: 141149.[Medline] [Order article via Infotrieve]
9. Zhang S, Yang Y, Kone BC, Allen JC, Kahn AM. Insulin-stimulated cyclic guanosine monophosphate inhibits vascular smooth muscle cell migration by inhibiting Ca/Calmodulin-dependent protein kinase II. Circulation. 2003; 107: 15391544.
10. Garg UC, Hasssid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989; 83: 17741777.[Medline] [Order article via Infotrieve]
11. Kahn AM, Lichtenberg RA, Allen JC, Seidel CL, Song T. Insulin-stimulated glucose transport inhibits Ca2+ influx and contraction in vascular smooth muscle. Circulation. 1995; 92: 15971603.
12. Kahn AM, Allen JC, Zhang S. Insulin increases NADH/NAD+ redox state, which stimulates guanylate cyclase in vascular smooth muscle. Am J Hypertens. 2002; 15: 273279.[CrossRef][Medline] [Order article via Infotrieve]
13. Omar HA, Mohazzab-H KM, Mortelliti MP, Wolin MS. O2- dependent modulation of calf pulmonary artery tone by lactate: potential role of H2O2 and cGMP. Am J Physiol. 1993; 264: L141L145.[Medline] [Order article via Infotrieve]
14. McIntyre M, Bohr DF, Dominiczak AF. Endothelial function in hypertension, the role of superoxide anion. Hypertension. 1999; 34: 539545.
15. Spoto G, Di Giulio C, Contento A, Di Stillo M. Hypoxic and hyperoxic effect on blood phosphodiesterase activity in young and old rats. Life Sci. 1998; 63: PL349PL353.[Medline] [Order article via Infotrieve]
16. Maclean MR, Johnston ED, Mcculloch KM, Pooley L, Houslay MD, Sweeney G. Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: changes in pulmonary hypertension. Pharmacol Exp Ther. 1997; 283: 619624.
17. Burke TM, Wolin MS. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am J Physiol. 1987; 252: H721H732.[Medline] [Order article via Infotrieve]
18. Fujimoto S, Mori M, Tsushima H. Mechanisms underlying the hydrogen peroxide-induced, endothelium-independent relaxation of the norepinephrine- contraction in guinea-pig aorta. Eur J Pharmacol. 2003; 459: 6573.[CrossRef][Medline] [Order article via Infotrieve]
19. Naseem KM, Mumtaz FH, Thompson CS, Sullivan ME, Khan MA, Morgan RJ, Mikhailidis DP, Bruckdorfer KR. Relaxation of rabbit lower urinary tract smooth muscle by nitric oxide and carbon monoxide: modulation by hydrogen peroxide. Eur J Pharmacol. 2000; 387: 329335.[Medline] [Order article via Infotrieve]
20. Wu C, Kuo S, Lee F, Teng C. YC-1 potentiated the antiplatelet effect of hydrogen peroxide via sensitization of soluble guanylate cyclase. Eur J Pharmacol. 1999; 381: 185191.[CrossRef][Medline] [Order article via Infotrieve]
21. Kahn AM, Allen JC, Seidel CL, Zhang S. Insulin inhibits migration of vascular smooth muscle cells with inducible nitric oxide synthase. Hypertension. 2000; 35: 303306.
22. Griending KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994; 74: 11411148.
23. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993; 91: 25462551.[Medline] [Order article via Infotrieve]
24. Cusson JR, Thembly J, LaRochelle P, Schifferin EL, Gutkowska J, Hamet P. Clinical relationships of cyclic GMP. In: Murad F, ed. Cyclic GMP, Synthesis, Metabolism and Function. San Diego, Calif: Academic Press; 1994: 305319.
25. Ioannidis I, Batz M, Paul T, Korth HG, Sustmann R, DeGroot H. Enhanced release of nitric oxide causes increased cytotoxicity of S-nitroso-N-acetyl-DL- penicillamine and sodium nitroprusside under hypoxic conditions. Biochem J. 1996; 318: 789795.[Medline] [Order article via Infotrieve]
26. Kahn AM, Seidel CL, Allen JC, ONeil RG, Shelat H, Song T. Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension. 1993; 22: 735742.
27. Kahn AM, Husid A, Allen JC, Seidel CL, Song T. Insulin acutely inhibits cultured vascular smooth muscle cell contraction by a nitric oxide synthase-dependent pathway. Hypertension. 1997; 30: 928933.
28. Brands MW, Lee WF, Keen HL, Alonso-Galacia M, Zappe DH, Hall JE. Cardiac output and renal function during insulin hypertension in Sprague-Dawley rats. Am J Physiol. 1996; 271: R276R281.[Medline] [Order article via Infotrieve]
29. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol. 1995; 268: L699L722.[Medline] [Order article via Infotrieve]
30. Gutpe S, Rupawalla T, Mohazzab-H KM, Wolin MS. Regulation of NO-elicited pulmonary artery relaxation and guanylate cyclase activation by NADH oxidase and SOD. Am J Physiol. 1999; 276: H1535H1542.[Medline] [Order article via Infotrieve]
31. Maytin M, Leoplold J, Loscalzo J. Oxidant stress in the vasculature. Curr Atheroscler Rep. 1999; 156164.
This article has been cited by other articles:
![]() |
E. Boedtkjer and C. Aalkjaer Insulin inhibits Na+/H+ exchange in vascular smooth muscle and endothelial cells in situ: involvement of H2O2 and tyrosine phosphatase SHP-2 Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H247 - H255. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Russo, P. Del Mese, G. Doronzo, L. Mattiello, M. Viretto, A. Bosia, G. Anfossi, and M. Trovati Resistance to the Nitric Oxide/Cyclic Guanosine 5'-Monophosphate/Protein Kinase G Pathway in Vascular Smooth Muscle Cells from the Obese Zucker Rat, a Classical Animal Model of Insulin Resistance: Role of Oxidative Stress Endocrinology, April 1, 2008; 149(4): 1480 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, A. Pearlman, Z. Luo, and C. S. Wilcox Hydrogen peroxide mediates a transient vasorelaxation with tempol during oxidative stress Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2085 - H2092. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |